Literature DB >> 16484698

Stability of parental understanding of random assignment in childhood leukemia trials: an empirical examination of informed consent.

Rachel Neff Greenley1, Dennis Drotar, Stephen J Zyzanski, Eric Kodish.   

Abstract

PURPOSE: To examine stability versus change in parental understanding of random assignment in randomized clinical trials (RCTs) for pediatric leukemia and to identify factors associated with changes in understanding.
METHODS: Eighty-four parents of children diagnosed with acute lymphoblastic leukemia or acute myeloid leukemia who were enrolled onto a pediatric leukemia RCT at one of six US children's hospitals participated. Parents were interviewed twice, once within 48 hours after the Informed Consent Conference (ICC; time 1 [T1]) and again 6 months later (time 2 [T2]). Interviews focused on parental understanding of key components of the RCT, including random assignment. Interviews were audiotaped, transcribed, and later analyzed.
RESULTS: Changes in understanding of random assignment occurred in 19% of parents, with 17% of parents deteriorating in understanding from T1 to T2. Forty-nine percent of parents failed to understand random assignment at both times. Factors associated with understanding at both times included majority ethnicity, high socioeconomic status, parental reading of consent document, and presence of a nurse during the ICC. Physician discussion of specific components of the RCT was also associated with understanding at both times. Female caregivers and parents of low socioeconomic status were overrepresented among those who showed decay in understanding from T1 to T2.
CONCLUSION: Parents showed little gain in understanding over time. Factors that predicted understanding at diagnosis as well as sustained understanding over time may be important intervention targets. Attention to both modifiable and nonmodifiable barriers is important for clinical practice.

Entities:  

Mesh:

Year:  2006        PMID: 16484698     DOI: 10.1200/JCO.2005.02.8100

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  10 in total

1.  Frontline ethical issues in pediatric clinical research: ethical and regulatory aspects of seven current bottlenecks in pediatric clinical research.

Authors:  Wim Pinxten; Herman Nys; Kris Dierickx
Journal:  Eur J Pediatr       Date:  2010-07-29       Impact factor: 3.183

Review 2.  Ethical aspects of clinical research with minors.

Authors:  Wendy Bos; Krista Tromp; Dick Tibboel; Wim Pinxten
Journal:  Eur J Pediatr       Date:  2012-10-17       Impact factor: 3.183

3.  Voluntary participation and informed consent to international genetic research.

Authors:  Patricia A Marshall; Clement A Adebamowo; Adebowale A Adeyemo; Temidayo O Ogundiran; Mirjana Vekich; Teri Strenski; Jie Zhou; T Elaine Prewitt; Richard S Cooper; Charles N Rotimi
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

4.  SUPPORT and the Ethics of Study Implementation: Lessons for Comparative Effectiveness Research from the Trial of Oxygen Therapy for Premature Babies.

Authors:  John D Lantos; Chris Feudtner
Journal:  Hastings Cent Rep       Date:  2014-12-19       Impact factor: 2.683

5.  Comparison of group counseling with individual counseling in the comprehension of informed consent: a randomized controlled trial.

Authors:  Rajiv Sarkar; Thuppal V Sowmyanarayanan; Prasanna Samuel; Azara S Singh; Anuradha Bose; Jayaprakash Muliyil; Gagandeep Kang
Journal:  BMC Med Ethics       Date:  2010-05-14       Impact factor: 2.652

6.  Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients.

Authors:  Tanguy Leroy; Véronique Christophe; Nicolas Penel; Pascal Antoine; Stéphanie Clisant
Journal:  Invest New Drugs       Date:  2009-09-18       Impact factor: 3.850

7.  Potential chemotherapy side effects: what do oncologists tell parents?

Authors:  Lisa Ysela Ramirez; Samantha E Huestis; Tsiao Yi Yap; Stephen Zyzanski; Dennis Drotar; Eric Kodish
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

8.  Development of the "Day 100 Talk": Addressing existing communication gaps during the early cancer treatment period in childhood cancer.

Authors:  Angela M Feraco; Sarah R Brand; Joshua Gagne; Amy Sullivan; Susan D Block; Joanne Wolfe
Journal:  Pediatr Blood Cancer       Date:  2018-01-31       Impact factor: 3.167

9.  Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study.

Authors:  Hélène Chappuy; Naim Bouazza; Veronique Minard-Colin; Catherine Patte; Laurence Brugières; Judith Landman-Parker; Anne Auvrignon; Dominique Davous; Hélène Pacquement; Daniel Orbach; Jean Marc Tréluyer; François Doz
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

10.  How do parents experience being asked to enter a child in a randomised controlled trial?

Authors:  Valerie Shilling; Bridget Young
Journal:  BMC Med Ethics       Date:  2009-02-16       Impact factor: 2.652

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.